Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


European Journal of Endocrinology, Vol 131, Issue 2, 201-204
Copyright © 1994 by European Society of Endocrinology
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ostenson, C.
Right arrow Articles by Efendic, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ostenson, C.
Right arrow Articles by Efendic, S

Articles

Inhibition by rat diazepam-binding inhibitor/acyl-CoA-binding protein of glucose-induced insulin secretion in the rat

CG Ostenson, B Ahren, S Karlsson, J Knudsen, and S Efendic

Department of Endocrinology, Karolinska Hospital, Stockholm, Sweden.

Diazepam-binding inhibitor (DBI) has been localized immunohistochemically in many organs. In porcine and rat pancreas, DBI is present in non-B-cells of the pancreatic islets. Porcine peptide also has been shown to suppress insulin secretion from rat pancreas in vitro. Recently, acyl-CoA-binding protein (ACBP) was isolated from rat liver and shown to be identical structurally to DBI isolated from rat brain. Using this rat DBI/ACBP, we have studied its effects on glucose-stimulated insulin secretion in the rat, both in vivo and in isolated pancreatic islets. Infusion iv of rDBI/ACBP (25 pmol/min) during glucose stimulation induced a moderate and transient reduction of plasma insulin levels. Moreover, rDBI/ACBP suppressed insulin release from batch-incubated isolated islets, stimulated by 16.7 mmol/l glucose, by 24% at 10 nmol/l (p < 0.05) and by 40% at 100 nmol/l (p < 0.01). The peptide (100 nmol/l) also inhibited the insulin response to glucose (16.7 mmol/l) from perifused rat islets by 31% (p < 0.05), mainly by affecting the acute-phase response. Finally, incubation of isolated islets in the presence of rDBI/ACBP antiserum (diluted 1:100 and 1:300) augmented the insulin response to 16.7 mmol/l glucose (p < 0.05 or even less). We conclude that rDBI/ACBP, administered iv or added to the incubation media, suppresses insulin secretion in the rat but that the effect is moderate despite the high concentration used. It is therefore unlikely that the peptide modulates islet hormone release, acting as a classical hormone via the circulation. However, the occurrence of DBI/ACBP in the islets and the enhancing effect by the rDBI/ACBP antibodies on glucose-stimulated insulin release suggest that the peptide is a local modulator of insulin secretion.


This article has been cited by other articles:


Home page
EndocrinologyHome page
O. Lesouhaitier, M. K. Kodjo, F. Cartier, V. Contesse, L. Yon, C. Delarue, and H. Vaudry
The Effect of the Endozepine Triakontatetraneuropeptide on Corticosteroid Secretion by the Frog Adrenal Gland Is Mediated by Activation of Adenylyl Cyclase and Calcium Influx through T-Type Calcium Channels
Endocrinology, January 1, 2000; 141(1): 197 - 207.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. V. Swinnen, P. Alen, W. Heyns, and G. Verhoeven
Identification of Diazepam-binding Inhibitor/Acyl-CoA-binding Protein as a Sterol Regulatory Element-binding Protein-responsive Gene
J. Biol. Chem., August 7, 1998; 273(32): 19938 - 19944.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. K. Schjerling, R. Hummel, J. K. Hansen, C. Borsting, J. M. Mikkelsen, K. Kristiansen, and J. Knudsen
Disruption of the Gene Encoding the Acyl-CoA-binding Protein (ACB1) Perturbs Acyl-CoA Metabolism in Saccharomyces cerevisiae
J. Biol. Chem., September 13, 1996; 271(37): 22514 - 22521.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 European Society of Endocrinology.